Quell Hype About New Quviviq for Insomnia

June 2022

You’ll hear buzz about Rx Quviviq (daridorexant) for insomnia.

It’s a me-too orexin antagonist...in the same family as Belsomra (suvorexant) and Dayvigo (lemborexant). All are C-IVs.

Quviviq will be touted to help patients fall asleep faster...stay asleep longer...and feel less tired during the day. Reps will also say it can be used nightly...with no max duration.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Aspirin Clear Up Confusion About Aspirin for CV Primary Prevention
Bites & Stings Answer Questions About Insect and Tick Repellents
Heart Failure Clarify New Heart Failure Terms and Management
Psychiatry Use a Practical Approach to Manage Agitation in Dementia
Med Safety Put PDE5 Inhibitor Risks in Perspective
Insomnia Quell Hype About New Quviviq for Insomnia
Travel Medicine Share Strategies to Prevent Blood Clots When Traveling
Cancer Help Overcome Barriers to Opioid Use for Cancer Pain
IBS Watch for Ibsrela for Irritable Bowel Syndrome

Quell Hype About New Quviviq for Insomnia

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents